Qiao‐Li Lv
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- Circular RNAs in diseases 12
- RNA modifications and cancer 6
- RNA Research and Splicing 4
-
- Cancer-related molecular mechanisms research 19
- MicroRNA in disease regulation 10
- Co-authors
- Hong‐Hao Zhou (13 shared papers)Shuhui Chen (10 shared papers)Hong‐Hao Zhou (5 shared papers)Lei Hu (10 shared papers)Chong-Zhen Qin (8 shared papers)Qiang Qu (6 shared papers)Guihua Wang (5 shared papers)Lihua Zhang (3 shared papers)
- Journals
- International Journal of Environmental Research and Public Health (4 papers)Frontiers in Genetics (3 papers)Bioorganic Chemistry (2 papers)International Immunopharmacology (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Qiao‐Li Lv
66 papers receiving 1.1k citations
Qiao‐Li Lv's Hit Papers
Peers
Comparison fields: 5 of 90
- Cancer Research 487
- Molecular Biology 649
- Pharmacology 42
- Genetics 40
- Immunology 77
Countries citing papers authored by Qiao‐Li Lv
This map shows the geographic impact of Qiao‐Li Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiao‐Li Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiao‐Li Lv more than expected).
Fields of papers citing papers by Qiao‐Li Lv
This network shows the impact of papers produced by Qiao‐Li Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiao‐Li Lv. The network helps show where Qiao‐Li Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Qiao‐Li Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 92 | |
| 2 | 2017 | 85 | |
| 3 | 2020 | 68 | |
| 4 | 2017 | 44 | |
| 5 | 2016 | 40 | |
| 6 | 2016 | 38 | |
| 7 | 2016 | 37 | |
| 8 | 2022 | 32 | |
| 9 | The role of artificial intelligence and machine learning in predicting and combating antimicrobial resistance Hit paper breakdown → | 2025 | 32 |
| 10 | 2015 | 31 | |
| 11 | 2017 | 30 | |
| 12 | 2020 | 29 | |
| 13 | 2023 | 29 | |
| 14 | 2015 | 28 | |
| 15 | 2021 | 25 | |
| 16 | 2019 | 24 | |
| 17 | 2016 | 24 | |
| 18 | 2016 | 23 | |
| 19 | 2016 | 23 | |
| 20 | 2022 | 23 |
About Qiao‐Li Lv
Qiao‐Li Lv is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Organic Chemistry, having authored 67 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (19 papers), Circular RNAs in diseases (12 papers), MicroRNA in disease regulation (10 papers), RNA modifications and cancer (6 papers), Ferroptosis and cancer prognosis (5 papers), RNA Research and Splicing (4 papers), Synthesis and biological activity (4 papers) and Glioma Diagnosis and Treatment (4 papers). The work is most often cited by research in Cancer Research (487 citations), Molecular Biology (649 citations), Pharmacology (42 citations), Genetics (40 citations) and Immunology (77 citations). Qiao‐Li Lv has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Hong‐Hao Zhou, Shuhui Chen, Hong‐Hao Zhou, Lei Hu, Chong-Zhen Qin, Qiang Qu, Guihua Wang, Lihua Zhang, Bao Sun and Lin Cheng. Their work appears in journals such as International Journal of Environmental Research and Public Health, Frontiers in Genetics, Bioorganic Chemistry, International Immunopharmacology and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.